Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medicare-funded cancer genetic tests: a note of caution.

The Medical journal of Australia - 3 Aug 2018

Kirk Judy, Barlow-Stewart Kristine K, Poplawski Nicola K, Gleeson Margaret, Tucker Kathy, Friedlander Michael

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Ovarian Neoplasms

Share to Patient Selection

Share to United States

Source

Identifiers

PMID: 30157409
DOI: 10.5694/mja17.01124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medicare-funded cancer genetic tests: a note of caution.PMID 30157409Read ↗

Management of Cancer Genetic Testing: A Brief Overview.Semantic proximity Read ↗

Are we any closer to genetic testing for common malignancies?Semantic proximity Read ↗

The changing landscape of hereditary cancer genetic testing.Semantic proximity Read ↗

Genetic testing in cancer therapeutics.Semantic proximity Read ↗

Call for action: expanding global access to hereditary cancer genetic testing.Semantic proximity Read ↗

Genetic testing for cancer: a complex decision.Semantic proximity Read ↗

Clinical applications of genetic technologies to cancer care.Semantic proximity Read ↗

Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Biomarker Tests Need Closer Scrutiny, IOM ConcludesSemantic proximity Read ↗

Can we really afford to spend NHS cash on genetic testing for cancer?Semantic proximity Read ↗

23andMe, the Food and Drug Administration, and the future of genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.